BEAT
HeartBeamANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-23
Current thesis
Ahead-of-schedule ALIGN-ACS enrollment and the licensing strategy provide tangible execution markers. Positive pilot data could improve the FDA pathway and expand the addressable market beyond current arrhythmia use.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
ALIGN-ACS results may not support a pivotal study, FDA discussions, or an expanded heart-attack indication.
Momentum
100
Value
37
Sentiment
61
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.65 · Bull $0.95 · Bear $0.30
Data freshness
Prices
As of 2026-07-23
Fundamentals
As of 2026-07-23 • Vendor: Data Vendor v1
Scores
As of 2026-07-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-18 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-23
Investment thesis
As of 2026-07-23
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $3.38
Why
Momentum100 · Δ7d -
Value37 · Δ7d -0.0
Sentiment61 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
100
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
61
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 99.9 / Value 36.5 / Sentiment 61.0
Fundamentals (TTM)As of 2026-07-23
Fundamentals (TTM)
As of 2026-07-23
Market Cap
$29.7M
Beta
-0.79
Shares Out
55.51M
P/E (TTM) · Derived
-0.9
P/S (TTM)
-
P/FCF (TTM) · Derived
-1.39
Rev YoY
-
EPS YoY
-35.8%
Gross Margin
-
Op Margin
-
Net Debt
-$4.38M
Current Ratio
0.74
As of 2026-07-23 • Updated nightlySource: Internal modelMethodology